(S)-4-(3-(Benzylthio)phenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95%, 500mg

4-Tolylacetic acid, 99.0%, 250g

(2-Bromophenylethynyl)trimethylsilane>98.0%(GC)5g

(3-Chloro-4-(ethylcarbamoyl)phenyl)boronic acid, 95.0%, 1g

2-(4-Bromophenyl)pyrrolidine>95.0%(GC)(T)200mg

Methyl 3-(((tert-butyldiphenylsilyl)oxy)methyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 98%, 100mg

1-(3,5-dimethylphenyl)-6-isopropylisoquinoline, 97%, 5g

TCPOBOP, 95%, 10mg

1,2-Bis[2-methylbenzo[b]thiophen-3-yl]-3,3,4,4,5,5-hexafluoro-1-cyclopentene (purified by sublimation)>99.0%(GC)100mg

(7S,7aR,14S,14aS)-Tetradecahydro-7,14-methanodipyrido[1,2-a:1',2'-e][1,5]diazocine, 95.0%, 1g

5-ethynyl-1H-pyrazolo[4,3-b]pyridine, 95+%, 250mg

tert-Butyl 1-(2-fluoro-4-methylbenzyl)piperidin-4-ylcarbamate, 95.0%, 1g

L-Proline monohydrochloride, 97%, 5g